tiprankstipranks
Crispr Therapeutics (CRSP)
:CRSP
US Market
Holding CRSP?
Track your performance easily

Crispr Therapeutics AG (CRSP) Technical Analysis

8,774 Followers

Technical Sentiment

Overall Consensus
Neutral
8Bullish
5Neutral
9Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Sell
5Bullish
0Neutral
7Bearish
Crispr Therapeutics’s (CRSP) Moving Averages Convergence Divergence (MACD) indicator is -1.62, suggesting Crispr Therapeutics is a Sell.
Crispr Therapeutics’s (CRSP) 20-Day exponential moving average is 41.26, while Crispr Therapeutics’s (CRSP) share price is $40.53, making it a Sell.
Crispr Therapeutics’s (CRSP) 50-Day exponential moving average is 44.04, while Crispr Therapeutics’s (CRSP) share price is $40.53, making it a Sell.

Crispr Therapeutics AG (CRSP) Pivot Points

Jan 21, 2025, 04:41 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
38.36
38.90
39.60
40.14
40.84
41.38
42.08
Fibonacci
38.90
39.37
39.67
40.14
40.61
40.91
41.38
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Crispr Therapeutics AG (CRSP) Moving Averages

Jan 21, 2025, 04:41 PM
Period
Simple
Exponential
MA5
39.42Buy
39.97Buy
MA10
40.34Buy
40.18Buy
MA20
40.38Buy
41.26Sell
MA50
45.65Sell
44.04Sell
MA100
46.43Sell
46.95Sell
MA200
51.13Sell
52.99Sell
Crispr Therapeutics’s (CRSP) 10-Day exponential moving average is 40.18, while Crispr Therapeutics’s (CRSP) share price is $40.53, making it a Buy.
Crispr Therapeutics’s (CRSP) 100-Day exponential moving average is 46.95, while Crispr Therapeutics’s (CRSP) share price is $40.53, making it a Sell.
Crispr Therapeutics’s (CRSP) stock price is $40.53 and Crispr Therapeutics’s (CRSP) 50-day simple moving average is 45.65, creating a Sell signal.
Crispr Therapeutics’s (CRSP) stock price is $40.53 and Crispr Therapeutics’s (CRSP) 100-day simple moving average is 46.43, creating a Sell signal.
Crispr Therapeutics’s (CRSP) stock price is $40.53 and Crispr Therapeutics’s (CRSP) 200-day simple moving average is 51.13, creating a Sell signal.

Crispr Therapeutics AG (CRSP) Technical Indicators

Jan 21, 2025, 04:41 PM
Name
Value
Implied Action
RSI (14)
44.09
Neutral
STOCH (9,6)
44.29
Neutral
STOCHRSI (14)
44.29
Neutral
MACD (12,26)
-1.62
Sell
ADX (14)
17.56
Buy
Williams %R
-48.32
Buy
CCI (14)
28.91
Neutral
ATR (14)
2.10
-
Ultimate Oscillator
43.17
Neutral
ROC
-1.31
Sell
Crispr Therapeutics’s (CRSP) Relative Strength Index (RSI) is 44.09, creating a Neutral signal.
Crispr Therapeutics’s (CRSP) Trend Strength Indicator (ADX) is 17.56, creating a Buy signal.
Crispr Therapeutics’s (CRSP) Commodity Channel Index (CCI) is 28.91, creating a Neutral signal.
Crispr Therapeutics’s (CRSP) Price Rate of Change (ROC) is -1.31, creating a Sell signal.

FAQ

Is CRSP a Buy, Hold, or Sell?
Based on CRSP’s technical indicators, CRSP is a Hold.
    What is CRSP’s RSI (14)?
    CRSP’s RSI (14) is 44.09, which suggests CRSP is a Neutral.
      What is CRSP’s MACD?
      CRSP’s MACD is -1.62, which suggests CRSP is a Sell.
        What is CRSP’s 5-day moving average?
        CRSP’s 5-day moving average is 39.42, which suggests CRSP is a Buy.
          What is CRSP’s 20-day moving average?
          CRSP 20-day moving average is 40.38, which suggests CRSP is a Buy.
            What is CRSP’s 50-day moving average?
            CRSP’s 50-day moving average is 45.65, which suggests CRSP is a Sell.
              What is CRSP’s 200-day moving average?
              CRSP’s 200-day moving average is 51.13, which suggests CRSP is a Sell.
                What is CRSP’s Williams % R (14)?
                CRSP’s Williams % R (14) is -48.32, which suggests CRSP is a Buy.
                  What is CRSP’s CCI (14)?
                  CRSP’s CCI (14) is 28.91, which suggests CRSP is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis